These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

713 related items for PubMed ID: 22728934

  • 21. Is serum sclerostin a marker of atherosclerosis in patients with chronic kidney disease-mineral and bone disorder?
    Figurek A, Spasovski G.
    Int Urol Nephrol; 2018 Oct; 50(10):1863-1870. PubMed ID: 30030677
    [Abstract] [Full Text] [Related]

  • 22. Relationship between Fibroblast Growth Factor 23 and Biochemical and Bone Histomorphometric Alterations in a Chronic Kidney Disease Rat Model Undergoing Parathyroidectomy.
    Liao HW, Hung PH, Hsiao CY, Liou HH, Lin HS, Huang TH, Jou IM, Tsai KJ.
    PLoS One; 2015 Oct; 10(7):e0133278. PubMed ID: 26186634
    [Abstract] [Full Text] [Related]

  • 23. Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease.
    Manghat P, Fraser WD, Wierzbicki AS, Fogelman I, Goldsmith DJ, Hampson G.
    Osteoporos Int; 2010 Nov; 21(11):1853-61. PubMed ID: 20012018
    [Abstract] [Full Text] [Related]

  • 24. Role of Chronic Kidney Disease (CKD)-Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD.
    Yamada S, Nakano T.
    J Atheroscler Thromb; 2023 Aug 01; 30(8):835-850. PubMed ID: 37258233
    [Abstract] [Full Text] [Related]

  • 25. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ, Shaheen FA.
    Saudi J Kidney Dis Transpl; 2010 Jan 01; 21(1):93-101. PubMed ID: 20061700
    [Abstract] [Full Text] [Related]

  • 26. Effects of ferric citrate and intravenous iron sucrose on markers of mineral, bone, and iron homeostasis in a rat model of CKD-MBD.
    Biruete A, Metzger CE, Chen NX, Swallow EA, Vrabec C, Clinkenbeard EL, Stacy AJ, Srinivasan S, O'Neill K, Avin KG, Allen MR, Moe SM.
    Nephrol Dial Transplant; 2022 Sep 22; 37(10):1857-1867. PubMed ID: 35482713
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [New Developments in CKD-MBD. Development and progression of CKD-MBD in predialysis period -when and how?].
    Komaba H.
    Clin Calcium; 2014 Dec 22; 24(12):1771-8. PubMed ID: 25423921
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function.
    Dhayat NA, Ackermann D, Pruijm M, Ponte B, Ehret G, Guessous I, Leichtle AB, Paccaud F, Mohaupt M, Fiedler GM, Devuyst O, Pechère-Bertschi A, Burnier M, Martin PY, Bochud M, Vogt B, Fuster DG.
    Kidney Int; 2016 Sep 22; 90(3):648-57. PubMed ID: 27370409
    [Abstract] [Full Text] [Related]

  • 32. The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease.
    Graciolli FG, Neves KR, Barreto F, Barreto DV, Dos Reis LM, Canziani ME, Sabbagh Y, Carvalho AB, Jorgetti V, Elias RM, Schiavi S, Moysés RMA.
    Kidney Int; 2017 Jun 22; 91(6):1436-1446. PubMed ID: 28318623
    [Abstract] [Full Text] [Related]

  • 33. miR-129 Blocks Secondary Hyperparathyroidism-Inducing Fgf23/αKlotho Signaling in Mice with Chronic Kidney Disease.
    Xu M, Li H, Bai Y, He J, Chen R, An N, Li Y, Dong Y.
    Am J Med Sci; 2021 May 22; 361(5):624-634. PubMed ID: 33781552
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho.
    Yamada S, Giachelli CM.
    Bone; 2017 Jul 22; 100():87-93. PubMed ID: 27847254
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Early chronic kidney disease-mineral bone disorder stimulates vascular calcification.
    Fang Y, Ginsberg C, Sugatani T, Monier-Faugere MC, Malluche H, Hruska KA.
    Kidney Int; 2014 Jan 22; 85(1):142-50. PubMed ID: 23884339
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.